Techh.info/biomedtechnology hourly

CRISPR

headlines texts
25.03.2019
19:08 Phys.orgNew CRISPR-powered device detects genetic mutations in minutes

A team of engineers at the University of California, Berkeley and the Keck Graduate Institute (KGI) of The Claremont Colleges combined CRISPR with electronic transistors made from graphene to create a new hand-held device that can detect specific genetic mutations in a matter of minutes.

Скрыть анонс
21.03.2019
17:33 ScienceDaily.comCRISPR/Cas libraries open new avenues in cancer research

CRISPR/Cas enables the targeted deactivation of genes by cutting DNA at pre-determined sites. This is accomplished by providing the Cas enzyme with a genetic zip code. Using an entire library of zip codes, it is then possible to simultaneously probe multiple sites within the genome, for example to determine which genes are essential for cancer cell survival. This could revolutionize drug discovery.

Скрыть анонс
15:53 Phys.orgCRISPR/Cas libraries open new avenues in cancer research

CRISPR/Cas enables the targeted deactivation of genes by cutting DNA at pre-determined sites. This is accomplished by providing the Cas enzyme with a genetic zip code. Using an entire library of zip codes, it is then possible to simultaneously probe multiple sites within the genome, for example to determine which genes are essential for cancer cell survival. This could revolutionize drug discovery.

Скрыть анонс
20.03.2019
21:13 News-Medical.NetCRISPR/Cas libraries could revolutionize drug discovery

CRISPR/Cas enables the targeted deactivation of genes by cutting DNA at pre-determined sites. This is accomplished by providing the Cas enzyme with a genetic zip code.

Скрыть анонс
02:08 Nature.ComWorld Health Organization panel weighs in on CRISPR-babies debate

Скрыть анонс
00:20 ScienceMag.orgWHO panel proposes new global registry for all CRISPR human experiments

The World Health Organization should also step up governance of human genome-editing research, group says

Скрыть анонс
19.03.2019
18:10 Phys.orgCRISPR gene editing: Why we need Slow Science

In a newly published article in Nature, a group of prominent scientists and ethicists have called for a moratorium on clinical research using CRISPR/Cas9 gene editing.

Скрыть анонс
16.03.2019
00:28 ScienceMag.orgCuring HIV just got more complicated. Can CRISPR help?

Scientists probe cellular hideouts for HIV and show that CRISPR can still cut the AIDS virus from DNA in monkeys

Скрыть анонс
15.03.2019
13:46 Technology.orgUC awarded third CRISPR patent, expanding its gene-editing portfolio

The University of California announced today that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent Number

Скрыть анонс
14.03.2019
19:09 FierceBiotech.comNew enzyme boosts 'CRISPR toolbox' for disease detection

Mammoth Biosciences is harnessing CRISPR to create diagnostic tools that can detect any biomarker containing DNA or RNA, with the ultimate goal of making tests that are as accessible and easy to use as a pregnancy test. It has just added the Cas14 enzyme to its arsenal.

Скрыть анонс
13.03.2019
21:08 TechnologyReview.comCRISPR experts are calling for a global moratorium on heritable gene editing

Some of the biggest names in gene editing want to stop anyone from playing around with cells that pass on changes to the next generation.

Скрыть анонс
15:33 NewScientist.ComHandheld device could detect CRISPR bioweapons before they spread

Bits of DNA known as gene drives that force themselves through a population could be use maliciously, but thankfully there is a way to detect them before they spread

Скрыть анонс
12.03.2019
12:53 Technology.orgNew CRISPR technique for studying gene function developed

When researchers want to understand a gene’s function, they silence or disable that gene in a model organism,

Скрыть анонс
11.03.2019
17:27 FierceBiotech.comSnipr raises $50M to use CRISPR to modulate the microbiome

Snipr Biome has raised $50 million to take CRISPR-based microbiome drugs into clinical trials. The Danish biotech is using CRISPR/Cas to selectively target and kill bacteria with specific DNA sequences. 

Скрыть анонс
07.03.2019
20:57 News-Medical.NetResearchers develop new method to boost efficiency of CRISPR gene editing in DMD

Scientists have developed a method to boost the efficiency of CRISPR gene editing in Duchenne muscular dystrophy (DMD), according to a study that could have implications for optimizing gene therapies for other diseases.

Скрыть анонс
02:44 ScienceDaily.comScientists find method to boost CRISPR efficiency

Scientists have developed a method to boost the efficiency of CRISPR gene editing in Duchenne muscular dystrophy (DMD), according to a study that could have implications for optimizing gene therapies for other diseases.

Скрыть анонс
00:35 Phys.orgScientists find method to boost CRISPR efficiency

Scientists have developed a method to boost the efficiency of CRISPR gene editing in Duchenne muscular dystrophy (DMD), according to a study that could have implications for optimizing gene therapies for other diseases.

Скрыть анонс
04.03.2019
19:13 ScienceMag.orgCorn and other important crops can now be gene edited by pollen carrying CRISPR

Syngenta’s new method could transform difficult-to-edit plants

Скрыть анонс
28.02.2019
23:19 ScienceMag.orgCRISPR offshoot still makes mistakes editing DNA, raising concerns about its medical use

A “base editor” that has great promise needs an upgrade

Скрыть анонс
27.02.2019
20:07 DigitalTrends.comChinese government may have helped fund controversial CRISPR babies experiment

A new report claims that the controversial CRISPR babies gene editing experiment in China might have been carried out with the support and funding of three Chinese governmental institutions, including China’s science ministry.
The post Chinese government may have helped fund controversial CRISPR babies experiment appeared first on Digital Trends.

Скрыть анонс
19:03 QuantaMagazine.orgDoudna’s Confidence in CRISPR’s Research Potential Burns Bright

Jennifer Doudna, one of CRISPR’s primary innovators, stays optimistic about how the gene-editing tool will continue to empower basic biological understanding.

Скрыть анонс
18:19 InvestorPlace.comCRISPR Therapeutics Rallies as Gene Stocks Get Hot Again

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
CRSP is testing its gene editing therapies in sicke cell disease and cancer. These therapies could eventually boost CRSP stock.
The post CRISPR Therapeutics Rallies as Gene Stocks Get Hot Again appeared first on InvestorPlace.
More From InvestorPlace 2 Toxic Pot Stocks You Should Avoid 7 Consumer Stocks to Buy and Hold for Years 4 China Stocks Soaring on Trade Hopes 3 Esports Stocks to Benefit From the Boom

Скрыть анонс
08:15 Yahoo ScienceBrainstorm Health: Virta Health Exclusive, Drug Pricing Hearing, Vertex CRISPR Trial

Brainstorm Health: Virta Health Exclusive, Drug Pricing Hearing, Vertex CRISPR Trial

Скрыть анонс
04:16 Gizmag First CRISPR therapy administered in landmark human trial


The first confirmed CRISPR gene editing clinical trial to take place outside of China is officially underway, with pharmaceutical companies CRISPR Therapeutics and Vertex revealing a human patient has been administered the experimental treatment targeting a rare blood disease.
.. Continue Reading First CRISPR therapy administered in landmark human trial Category: Science Tags: CRISPR Genetics

Скрыть анонс
26.02.2019
22:09 ScienceDaily.comCRISPR reveals the secret life of antimicrobial peptides

Using CRISPR, scientists have carried out extensive work on a little-known yet effective weapon of the innate immune system, antimicrobial peptides.

Скрыть анонс
19:51 Yahoo.com BusinessCRISPR Therapeutics Up as Dosing Starts in Thalassemia Study

CRISPR Therapeutics (CRSP) and partner Vertex start dosing of beta thalassemia patients in an early-stage study evaluating gene editing therapy, CTX001. Initiates enrollment in sickle cell disease study.

Скрыть анонс
17:28 Nature.ComThe CRISPR-baby scandal: what’s next for human gene-editing

Скрыть анонс
16:24 Phys.orgDistorted, stretched DNA may increase risk of off-target changes with CRISPR-Cas9

Distortions to DNA, which occur routinely during gene expression and other cellular processes, could lead to off-target changes to the genome when using CRISPR-Cas9, a new study suggests. The Medical Research Council scientists behind the research say that their findings may help to pave the way to improve on the accuracy of gene editing for clinical applications.

Скрыть анонс
14:34 Nature.ComTraditional Islamic approach can enrich CRISPR twins debate

Скрыть анонс
05:10 ScienceDaily.comManipulating gene expression in neurons with CRISPR

Neuroscientists have used CRISPR/Cas9 genome editing technology to regulate genes in the rat brain. This technique paves the way for researchers to probe genetic influences on brain health and disease in model organisms that more closely resemble human conditions.

Скрыть анонс
00:55 Yahoo.com BusinessWhy Danaher, CRISPR Therapeutics, and Clementia Pharmaceuticals Jumped Today

A big day in biotech helped lift the market.

Скрыть анонс
25.02.2019
19:59 TechnologyReview.comCRISPR is being used to treat a patient with a dangerous blood disease

Скрыть анонс
16:33 News-Medical.NetUsing CRISPR to regulate genes in the rat brain

Neuroscientists have used CRISPR/Cas9 genome editing technology to regulate genes in the rat brain. Described in eNeuro, this technique paves the way for researchers to probe genetic influences on brain health and disease in model organisms that more closely resemble human conditions.

Скрыть анонс
23.02.2019
02:33 DigitalTrends.comControversial CRISPR baby experiment may have resulted in brain enhancements

China’s CRISPR baby saga continues to rage on. Scientists have now expressed concerns that the procedure may have also resulted in changes in the babies’ brains affecting cognition.
The post Controversial CRISPR baby experiment may have resulted in brain enhancements appeared first on Digital Trends.

Скрыть анонс
22.02.2019
22:33 TechnologyReview.comChina’s CRISPR twins: A time line of news

It’s been three months since news broke that twin girls had been genetically modified using CRISPR. There’s a lot to catch up on.

Скрыть анонс
13:49 Technology.orgCRISPR Gene Editing Makes Stem Cells ‘Invisible’ to Immune System

UC San Francisco scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that

Скрыть анонс
21.02.2019
21:14 Phys.orgNew strategy improves efficiency of CRISPR-Cas9 genome editing

The efficiency of CRISPR genome editing tools targeted to the site of interest by Cas9 nucleases varies considerably and a new CMP-fusion strategy, called CRISPR-chrom, enhances the activity up to several-fold. CRISPR-chrom works by fusing a Cas9 to chromatin-modulating peptides (CMPs), as described in an article published in The CRISPR Journal.

Скрыть анонс
19:11 TechnologyReview.comThe CRISPR twins had their brains altered

New research suggests that a controversial gene-editing experiment to make children resistant to HIV may also have enhanced their ability to learn and form memories.

Скрыть анонс
10:12 Gizmag Geneticists use CRISPR to cut toxic protein out of the aging equation


There is much we don't understand about an aging human body, but working with what we do know researchers continue to uncover potential new was to slow down the process. Among them is a team of genetic scientists at the Salk Institute, which has developed a new therapy using the CRISPR/Cas9 tool that has greatly boosted the lifespan of rapidly aging mice.
.. Continue Reading Geneticists use CRISPR to cut toxic protein out of the aging equation Category: Medical Tags: Aging anti-aging CRISPR Salk Institute

Скрыть анонс
19.02.2019
22:44 Nature.ComFaster, better, cheaper: the rise of CRISPR in disease detection

Скрыть анонс
20:05 ScienceDaily.comCRISPR/Cas9 therapy can suppress aging, enhance health and extend life span in mice

Researchers have developed a new gene therapy to help decelerate the aging process. The findings highlight a novel CRISPR/Cas9 genome-editing therapy that can suppress the accelerated aging observed in mice with Hutchinson-Gilford progeria syndrome, a rare genetic disorder that also afflicts humans.

Скрыть анонс
16:18 Nature.ComAdventures of a bathynaut, art goes algorithmic, and CRISPR encapsulated: Books in brief

Скрыть анонс
05:02 Gizmag Landmark research creates “universal” stem cells using CRISPR gene editing


In an incredible milestone, scientists have for the first time created "universal" stem cells by using CRISPR gene-editing technology to produce pluripotent stem cells that can be transplanted into any patient without generating an immune system response.
.. Continue Reading Landmark research creates “universal” stem cells using CRISPR gene editing Category: Science Tags: CRISPR Stem Cells The Immune System Transplant

Скрыть анонс
18.02.2019
21:52 News-Medical.NetSingle CRISPR treatment can safely and stably correct genetic disease

Researchers at Duke University have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease -- Duchenne muscular dystrophy (DMD) -- for more than a year in mice, despite observed immune responses and alternative gene editing outcomes.

Скрыть анонс
21:27 ScienceDaily.comDMD: Single CRISPR treatment provides long-term benefits in mice

Researchers have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease -- Duchenne muscular dystrophy (DMD) -- for more than a year in mice, despite observed immune responses and alternative gene editing outcomes.

Скрыть анонс
21:18 News-Medical.NetCRISPR technology creates pluripotent stem cells that are 'invisible' to the immune system

UC San Francisco scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally "invisible" to the immune system, a feat of biological engineering that, in laboratory studies, prevented rejection of stem cell transplants.

Скрыть анонс
19:05 FierceBiotech.comCRISPR corrects DMD in mice for a year in Sarepta-supported study

A Duke lab at the center of a research pact with Sarepta is reporting promising results from a trial of CRISPR gene editing in mouse models of DMD. But the treatment has produced some off-target effects, which the researchers plan to investigate further in future studies.

Скрыть анонс
13:02 StemCellsPortal.comlEnhancing CRISPR/Cas9 Gene Editing of Human Hematopoietic Stem Cells

Review of “Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA Repair” from STEM CELLS by Stuart P. Atkinson 

The DNA double-strand breaks generated by the CRISPR/Cas9 gene editing system can be repaired throughout the cell cycle by the error‐prone non-homologous end joining (NHEJ) pathway or during S/G2 phases by the more precise homology‐directed repair (HDR). The application of HDR‐mediated gene editing in human hematopoietic stem cells to precisely correct disease‐causing mutations suffers from a relatively low efficiency in primitive long‐term reconstituting stem cells [1-3], which currently prohibits the exploration of ex vivo correction of hematopoietic stem cells as a therapeutic option for a range of diseases/disorders.

In a new STEM CELLS

Скрыть анонс
15.02.2019
15:33 NewScientist.ComMeet the man who made CRISPR monkey clones to study depression

Hung-Chun Chang told New Scientist about his team’s controversial project to find drugs for depression and schizophrenia using clones of gene-edited monkeys

Скрыть анонс
14.02.2019
20:57 NewScientist.ComCRISPR could help us protect ourselves from viruses like flu and HIV

Gene-edited white blood cells could let us hack our immune systems to prevent infections with pathogens like HIV, flu, and the virus that causes glandular fever

Скрыть анонс
19:09 Nature.ComAuthor Correction: Predictable and precise template-free CRISPR editing of pathogenic variants

Скрыть анонс
11.02.2019
20:47 Yahoo.com BusinessHere's Why CRISPR Therapeutics Rose 13.5% in January

The gene-editing pioneer announced a new regulatory designation for its lead drug candidate.

Скрыть анонс
14:51 Technology.orgNew anti-CRISPR proteins discovered in soil and human gut

CRISPR systems are bacterial immune systems that enable the bacterium to fight off infecting viruses (phages) in a

Скрыть анонс
09:50 Technology.orgScientists find new and smaller CRISPR gene editor: CasX

In a mere seven years, Cas9 has shown itself to be a formidable gene editor, employed in humans,

Скрыть анонс
09.02.2019
04:14 Reuters.com ScienceUniversity of California to be granted pioneering CRISPR patent

The University of California will soon be granted a potentially valuable patent on the revolutionary gene-editing technology known as CRISPR, according to a document filed by the U.S. patent office on Friday.

Скрыть анонс
08.02.2019
23:24 ScienceMag.orgNew patent win for University of California upends CRISPR legal battle

Companies may have to license patents on genome editor from multiple places

Скрыть анонс
22:41 Reuters.com ScienceUniversity of California to be granted CRISPR patent

The University of California will soon be granted a potentially valuable patent on the revolutionary gene-editing technology known as CRISPR, according to a document filed by the U.S. patent office on Friday.

Скрыть анонс
16:47 Phys.orgNested CRISPR enables efficient genome editing using long DNA fragments

CRISPR is a technique that is revolutionizing biomedical research through high-precision genome editing. However, even though it allows the creation or correction of mutations consisting of a single or few nucleotides with relative ease, it still possesses limitations for larger fragments of DNA in the genome. For instance, the genomic insertion of a gene that produces a fluorescent protein such as the widely-used GFP suffers from poor efficiency and involves complicated cloning steps.

Скрыть анонс
15:54 SeekingAlpha.comBTIG likes CRISPR/Cas9 gene editors in premarket analyst action

Скрыть анонс
10:37 News-Medical.NetCloning-free Nested CRISPR method uses long DNA fragments for efficient gene editing

CRISPR is a technique that is revolutionizing biomedical research through high-precision genome editing. However, even though it allows the creation or correction of mutations consisting of a single or few nucleotides with relative ease, it still possesses limitations upon introducing larger fragments of DNA in the genome.

Скрыть анонс
07.02.2019
21:54 ScienceDaily.comThe novel method Nested CRISPR enables efficient genome editing using long DNA fragments

Researchers used the model organism Caenorhabditis elegans to optimize a new technique, leading to the development of the method called Nested CRISPR. This cloning-free method involves the insertion of long DNA fragments in two steps.

Скрыть анонс
14:09 TechnologyReview.comStanford will investigate its role in the Chinese CRISPR baby debacle

The university wants to learn what ties its faculty members had to He Jiankui, the researcher who created gene-edited humans.

Скрыть анонс
06.02.2019
21:15 Nature.ComPodcast: Massive chemical libraries, and CRISPR-CasX

Скрыть анонс
16:54 Geek.comScientists Uncover New, Smaller CRISPR Gene Editor

Move over, Cas9: There’s a new gene editor in town. CasX, discovered two years ago by UC Berkeley scientists Jill Banfield and Jennifer Doudna, is a potent and efficient reviser of bacteria and […]
The post Scientists Uncover New, Smaller CRISPR Gene Editor appeared first on Geek.com.

Скрыть анонс
16:42 Phys.orgNew anti-CRISPR proteins discovered in soil and human gut

Scientists from the Novo Nordisk Foundation Center for Biosustainability (DTU) have found four new anti-CRISPR proteins that are distributed across different environments. The new study published in Cell Host & Microbe suggests that some anti-CRISPR proteins are more widespread in nature than previously anticipated. These anti-CRISPRs can potentially be used to regulate the activity of CRISPR-Cas9 systems better in the future.

Скрыть анонс
11:08 Gizmag CRISPR-CasX could be the next small gene-editing enzyme


In the world of gene-editing, CRISPR and Cas9 usually go hand in hand, but that might not necessarily be the best pairing. The Cas9 protein has proven effective over the last few years, but alternatives, such as Cas12a and Cas12b, are quickly emerging. Now, researchers at UC Berkeley have tested a new candidate, CasX, which seems to have a few advantages of its own.
.. Continue Reading CRISPR-CasX could be the next small gene-editing enzyme Category: Medical Tags: Bacteria CRISPR Enzyme Genetic engineering Genome Protein UC Berkeley

Скрыть анонс
00:46 ScienceDaily.comNew anti-CRISPR proteins discovered in soil and human gut

Scientists have found four new anti-CRISPR proteins that are distributed across different environments. The new study suggests that some anti-CRISPR proteins are more widespread in nature than previously anticipated. These anti-CRISPRs can potentially be used to regulate the activity of CRISPR-Cas9 systems better in the future.

Скрыть анонс
05.02.2019
15:16 Phys.orgScientists find new and smaller CRISPR gene editor: CasX

In a mere seven years, Cas9 has shown itself to be a formidable gene editor, employed in humans, plants, animals and bacteria to quickly and accurately cut and splice DNA, transforming biology and opening new avenues for treating disease.

Скрыть анонс
14:22 Yahoo.com BusinessWhy Even a Pessimistic Analyst Thinks CRISPR Therapeutics Will Jump 20%

A huge downgrade for this gene-editing biotech still has a nice silver lining.

Скрыть анонс
31.01.2019
18:14 NewScientist.ComVirus lurking inside banana genome has been destroyed with CRISPR

A virus that inserts itself into the genome of a type of banana plagues plantations in Africa, but CRISPR gene editing can be used to eliminate the viral DNA

Скрыть анонс
17:08 NewScientist.ComVirus threatening to wipe out bananas can be destroyed using CRISPR

A virus that inserts itself into the banana genome could destroy plantations, but CRISPR gene editing has been used to eliminate the viral DNA

Скрыть анонс
30.01.2019
16:19 News-Medical.NetPromega signs license agreement with Broad Institute to access CRISPR-Cas9 technology

Promega Corporation announced today it has signed a non-exclusive license agreement with the Broad Institute of MIT and Harvard to sell tools and reagents for CRISPR-Cas9 gene editing, providing scientists new tools for interrogating endogenous biology.

Скрыть анонс
13:29 NewScientist.ComUsing CRISPR to stop male calves being born may lower animal suffering

Male cows and chickens are routinely killed soon after birth because they are not wanted, but it may be possible to prevent their embryos developing in the first place

Скрыть анонс
07:27 News-Medical.NetPromega signs license agreement with Broad Institute to sell tools for CRISPR-Cas9 gene editing

Promega Corporation announced today it has signed a non-exclusive license agreement with the Broad Institute of MIT and Harvard to sell tools and reagents for CRISPR-Cas9 gene editing, providing scientists new tools for interrogating endogenous biology.

Скрыть анонс
29.01.2019
20:16 NewScientist.ComUsing CRISPR to stop male cows being born may reduce animal suffering

Male cows and chickens are routinely killed soon after birth because they are not wanted, but it may be possible to prevent their embryos developing in the first place

Скрыть анонс
25.01.2019
17:15 FierceBiotech.comVertex strikes deal with Merck KGaA to grow CRISPR/Cas9 toolkit

Vertex has regained limited rights to two DNA-dependent protein kinase inhibitors from Merck KGaA. Merck licensed the drugs and other assets for $230 million upfront two years ago but has now granted Vertex the right to use them in certain gene-editing applications. 

Скрыть анонс
07:24 Gizmag CRISPR gene-edited monkeys cloned in China


New research out of China has confirmed the birth of five-gene-edited monkey clones. Two recently published papers describe how a CRISPR-gene edited long-tailed macaque has been successfully cloned demonstrating the first time in the world a gene-edited monkey has been effectively cloned.
.. Continue Reading CRISPR gene-edited monkeys cloned in China Category: Science Tags: China Cloning CRISPR Genetics Monkeys

Скрыть анонс
24.01.2019
10:19 Technology.orgUC San Diego Researchers First to Use CRISPR/Cas9 to Control Genetic Inheritance in Mice

Biologists at the University of California San Diego have developed the world’s first CRISPR/Cas9-based approach to control genetic

Скрыть анонс
08:52 Gizmag CRISPR used to control which genes are passed down in mice


Humans have been tinkering with evolution for millennia, breeding plants and animals to favor the traits we want, but new research might make the process a bit more direct. Biologists at the University of California San Diego have successfully used the CRISPR gene-editing tool to control genetic inheritance in mice for the first time.
.. Continue Reading CRISPR used to control which genes are passed down in mice Category: Biology Tags: CRISPR Genetic engineering Genetics Mouse UCSD

Скрыть анонс
23.01.2019
21:54 ScienceDaily.comCRISPR/Cas9 used to control genetic inheritance in mice

Using active genetics technology, biologists have developed the world's first CRISPR/Cas9-based approach to control genetic inheritance in a mammal. The achievement in mice lays the groundwork for further advances based on this technology, including biomedical research on human disease. Future animal models may be possible of complex human genetic diseases, like arthritis and cancer, which are not currently possible.

Скрыть анонс
21:10 Nature.ComSuper-Mendelian inheritance mediated by CRISPR–Cas9 in the female mouse germline

Скрыть анонс
21:03 Phys.orgResearchers first to use CRISPR/Cas9 to control genetic inheritance in mice

Biologists at the University of California San Diego have developed the world's first CRISPR/Cas9-based approach to control genetic inheritance in a mammal.

Скрыть анонс
18:05 SingularityHub.ComCRISPR Just Got More Powerful With an “On” Switch

For all its gene-editing prowess, mechanistically CRISPR is a bit like a power tool with a broken “off” switch. Hear me out: the entire CRISPR machinery is designed in a test tube, and once constructed it’s always on. When introduced into animals or humans, CRISPR is set to roam the entire body, seeking its target […]

Скрыть анонс
16:32 Yahoo.com BusinessBetter Buy: CRISPR Therapeutics vs. Editas Medicine

Which of these gene-editing stocks has the best chance to boost your portfolio?

Скрыть анонс
16:15 Nature.ComCRISPR-baby scientist, German publishing deal and hunger strike

Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.

Скрыть анонс
15:12 Phys.orgScientists engineer new CRISPR platform for DNA targeting

A team that includes the scientist who first harnessed the revolutionary CRISPR-Cas9 and other systems for genome editing of eukaryotic organisms, including animals and plants, has engineered another CRISPR system, called Cas12b. The new system offers improved capabilities and options when compared to CRISPR-Cas9 systems.

Скрыть анонс
10:26 Technology.orgScientists engineer new CRISPR platform for DNA targeting

A team that includes the scientist who first harnessed the revolutionary CRISPR-Cas9 and other systems for genome editing

Скрыть анонс
05:36 Gizmag New CRISPR enzyme makes for more precise gene-editing


The CRISPR gene-editing tool may be one of the most important medical breakthroughs in decades, but there's still plenty of room for improvement. Although Cas9 has been the go-to enzyme for gene-editing, that doesn't mean it's necessarily the best option. Now a team of scientists, including the co-creator of CRISPR, has engineered a more precise enzyme, known as Cas12b.
.. Continue Reading New CRISPR enzyme makes for more precise gene-editing Category: Medical Tags: CRISPR Enzyme Genetic engineering Genetics Genome MIT

Скрыть анонс
03:18 Yahoo.com BusinessShould You Sell CRISPR Therapeutics Following an Analyst Downgrade?

Citigroup has downgraded the gene-editing pioneer to "sell," but Wall Street has been known to make mistakes.

Скрыть анонс
02:17 ScientificAmerican.ComScientist Behind "CRISPR Babies" Fired by University

An investigation by Chinese authorities found He Jiankui broke national regulations in his controversial gene editing work -- Read more on ScientificAmerican.com

Скрыть анонс
22.01.2019
23:10 DigitalTrends.comThe CRISPR baby saga continues as China confirms second gene-edited pregnancy

China’s official Xinhua news agency has confirmed that a second woman has become pregnant as part of a controversial experiment to create the world’s first genetically edited babies.
The post The CRISPR baby saga continues as China confirms second gene-edited pregnancy appeared first on Digital Trends.

Скрыть анонс
22:31 Nature.ComCRISPR-baby scientist fired by university

Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.

Скрыть анонс
21:42 SeekingAlpha.comEditas and CRISPR weigh on biotechs, XBI down 3%

Скрыть анонс
21:36 ScienceDaily.comEffective strategies for safeguarding CRISPR gene-drive experiments

Researchers have demonstrated for the first time how two molecular strategies can safeguard CRISPR gene-drive experiments in the lab, according to a new study.

Скрыть анонс
20:02 Yahoo.com BusinessHere's Why CRISPR Therapeutics Stock Fell Today

A Wall Street analyst isn't too optimistic about the company's lead candidate.

Скрыть анонс
18:21 Phys.orgScientists demonstrate effective strategies for safeguarding CRISPR gene-drive experiments

Researchers have demonstrated for the first time how two molecular strategies can safeguard CRISPR gene-drive experiments in the lab, according to a study published today in eLife.

Скрыть анонс
17:59 FierceBiotech.com'In genome Editas': Bosley signs off from CRISPR pioneer

Just a few months after getting the all-clear to start its first CRISPR trial and bagging a nice check from Allergan in the process, Editas’ chief executive and president Katrine Bosley is hitting the exit.

Скрыть анонс
15:59 SeekingAlpha.comCiti cuts CRISPR Therapeutics to Sell, shares down 7% premarket

Скрыть анонс
00:05 ScienceMag.orgScientist behind CRISPR twins sharply criticized in government probe, loses job

He Jiankui hid his work and used false blood tests, preliminary report says

Скрыть анонс
21.01.2019
16:33 TechnologyReview.comCRISPR babies are real and the scientist who made them sought “personal fame and fortune”

Скрыть анонс
First← Previous12345678910Previous →Last